Review
Published on 18 Jan 2021
Pulmonary Micro-Ecological Changes and Potential Microbial Markers in Lung Cancer Patients
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.576855
- 4,903 views
- 9 citations
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,749 articles
Original Research
Published on 14 Jan 2021
Protein Glycopatterns in Bronchoalveolar Lavage Fluid as Novel Potential Biomarkers for Diagnosis of Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.568433
- 3,896 views
- 7 citations
Systematic Review
Published on 12 Jan 2021
Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.586596
- 10,711 views
- 62 citations
Original Research
Published on 11 Jan 2021
Predictors of CT Morphologic Features to Identify Spread Through Air Spaces Preoperatively in Small-Sized Lung Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.548430
- 6,013 views
- 26 citations
Original Research
Published on 11 Jan 2021
Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.603671
- 4,900 views
- 13 citations
Systematic Review
Published on 11 Jan 2021
Efficacy and Safety of PD-1/PD-L1 Inhibitors Plus Chemotherapy Versus PD-1/PD-L1 Inhibitors in Advanced Non-Small Cell Lung Cancer: A Network Analysis of Randomized Controlled Trials
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.574752
- 7,035 views
- 17 citations
Original Research
Published on 08 Jan 2021
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.590356
- 4,048 views
- 6 citations
Original Research
Published on 08 Jan 2021
MYBL2-Driven Transcriptional Programs Link Replication Stress and Error-prone DNA Repair With Genomic Instability in Lung Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.585551
- 7,720 views
- 13 citations
Original Research
Published on 06 Jan 2021
Changes of Brain Structure in Patients With Metastatic Non-Small Cell Lung Cancer After Long-Term Target Therapy With EGFR-TKI
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.573512
- 5,156 views
- 3 citations
Original Research
Published on 23 Dec 2020
Relevance of STK11 Mutations Regarding Immune Cell Infiltration, Drug Sensitivity, and Cellular Processes in Lung Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.580027
- 5,822 views
- 12 citations
Original Research
Published on 23 Dec 2020
Dyspnea in Patients Receiving Radical Radiotherapy for Non-Small Cell Lung Cancer: A Prospective Study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.594590
- 3,472 views
- 8 citations
Original Research
Published on 22 Dec 2020
Thymic Squamous Cell Carcinoma: A Population-Based Surveillance, Epidemiology, and End Result Analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.592023
- 8,838 views
- 15 citations
Original Research
Published on 21 Dec 2020
Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.608300
- 4,248 views
- 9 citations
Review
Published on 18 Dec 2020
Development of EGFR TKIs and Options to Manage Resistance of Third-Generation EGFR TKI Osimertinib: Conventional Ways and Immune Checkpoint Inhibitors
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.602762
- 39,212 views
- 85 citations
Case Report
Published on 17 Dec 2020
Lung Adenocarcinoma Harboring EGFR Kinase Domain Duplication (EGFR-KDD) Confers Sensitivity to Osimertinib and Nivolumab: A Case Report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.575739
- 3,863 views
- 5 citations
Original Research
Published on 16 Dec 2020
Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.593831
- 7,015 views
- 32 citations